SCHEMBL651655

SCHEMBL651655

CCC[CH]N1CCOCC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.34
ALDH1A1 P00352 5/20 0.33
HTT P42858 2/20 0.32
MAPT P10636 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
TSHR P16473 1/20 0.32
LMNA P02545 3/20 0.32
POLB P06746 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
RECQL P46063 1/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
MAPK1 P28482 2/20 0.31
CYP1A2 P05177 1/20 0.31
CHRM2 P08172 1/20 0.31
CHRM1 P11229 1/20 0.31
HTR2A P28223 1/20 0.31
SCN1A P35498 1/20 0.31
HTR2B P41595 1/20 0.31
KCNH2 Q12809 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17393404 0.86 HTT (0.37) GAAALDH1A1HTTMAPTL3MBTL1
SCHEMBL17393101 0.85 CNR1 (0.36) GAAALDH1A1HTTTSHRLMNA
SCHEMBL7676216 0.83 CNR1 (0.38) ALDH1A1HTTTSHRLMNAPOLB
SCHEMBL1447953 0.82
SCHEMBL55843 0.80
SCHEMBL3308128 0.77 ALDH1A1 (0.37) GAAALDH1A1HTTMAPTL3MBTL1
SCHEMBL378009 0.77
SCHEMBL1448045 0.77
SCHEMBL4344429 0.76
SCHEMBL17393323 0.76 TSHR (0.34) ALDH1A1HTTMAPTL3MBTL1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117843566-A Polysubstituted benzene derivative, composition and use thereof 康迈迪森(北京)医药科技有限公司 2024-04-09 CN claimed
CN-117050043-A 3-phenyl dibenzofuran compound and preparation method and application thereof 中国海洋大学 2023-11-14 CN claimed
CN-112898286-A Benzothiophene compound or pharmaceutically acceptable salt and isomer thereof, and preparation method, pharmaceutical composition and application thereof 中国药科大学 2021-06-04 CN claimed
EP-2027123-B1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2011-02-23 EP claimed
US-7846923-B2 Compounds and compositions as protein kinase inhbitors IRM LLC (BM) 2010-12-07 US claimed
US-20100048552-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHBITORS IRM LLC (BM) 2010-02-25 US claimed
EP-2027123-A2 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2009-02-25 EP claimed
WO-2007134259-A2 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2007-11-22 WO claimed
EP-0927171-B1 PYRAZINONES AND TRIAZINONES AND THEIR DERIVATIVES THEREOF DU PONT PHARM CO (US) 2002-02-20 EP claimed
US-6218391-B1 CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS USED IN THERAPY OF PSYCHIATRIC DISORDERS AND NEUROLOGICAL DISEASES SUCH AS MAJOR DEPRESSION, ANXIETY-RELATED DISORDER, POST-TRAUMATIC STRESS DISORDER, SUPRANUCLEAR PALSY DUPONT PHARMACEUTICALS COMPANY 2001-04-17 US claimed
US-6159980-A Pyrazinones and triazinones and their derivatives thereof DUPONT PHARMACEUTICALS COMPANY (US) 2000-12-12 US claimed
EP-0927171-A1 PYRAZINONES AND TRIAZINONES AND THEIR DERIVATIVES THEREOF Du Pont Pharmaceuticals Company (US) 1999-07-07 EP claimed
WO-1998011075-A1 PYRAZINONES AND TRIAZINONES AND THEIR DERIVATIVES THEREOF DU PONT PHARMACEUTICALS COMPANY (US) 1998-03-19 WO claimed
US-4410536-A 7,8,9,10-Tetrahydrothieno[3,2-e]pyrido[4,3-b]indole compounds and their anti-depressant use TROPONWERKE GMBH & CO. K.G. (DE) 1983-10-18 US claimed
EP-4374877-A2 PHARMACEUTICAL CONTAINING SODIUM-DEPENDENT PHOSPHATE TRANSPORTER INHIBITOR AND PHOSPHORUS ADSORBENT FOR USE IN THE PREVENTION, TREATMENT OR SUPPRESSION OF CHRONIC KIDNEY DISEASE, ARTERIOSCLEROSIS ASSOCIATED WITH VASCULAR CALCIFICATION, OR ECTOPIC CALCIFICATION. CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-05-29 EP disclosed
WO-2024106213-A1 METHOD FOR PRODUCING DISILOXANE COMPOUND 信越化学工業株式会社 2024-05-23 WO disclosed
CN-117843566-A Polysubstituted benzene derivative, composition and use thereof 康迈迪森(北京)医药科技有限公司 2024-04-09 CN disclosed
US-4125403-A ORGANIC SILVER SALT, SILVER HALIDE, REDUCING AGENT, PHTHALAZINONE, AND A BENZOXAZINEDIONE OR QUINAZOLINEDIONE FUJI PHOTO FILM CO., LTD. 1978-11-14 US disclosed
US-4076534-A Heat developable light-sensitive material FUJI PHOTO FILM CO., LTD. (JA) 1978-02-28 US disclosed
US-3979380-A INOTROPIC ACTIVITY, CARDIAC STIMULANTS AMERICAN HOME PRODUCTS CORPORATION (US) 1976-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048552-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHBITORS BMX, FYN, FRK GAA 2094/4885ALDH1A1 4202/4885HTT 3389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.